Regenxbio RGNX Earnings Call Transcripts

NASDAQ RGNX
$7.69 -0.38 (-4.71%)
At close: Nov 10, 2026 · 4:00 PM EST
12 earnings calls on file for Regenxbio, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Regenxbio Q3 2026 Earnings Call

Nov 5, 2026 6,436 words · 28 min read
  • Patrick ChristmasChief Legal Officer
  • Curran SimpsonPresident and Chief Executive Officer
  • Steve PakolaChief Medical Officer
  • Mitch ChanChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Regenxbio Earnings Call Transcripts

Calls12
LatestNov 5, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 12 Regenxbio transcripts Register to get access to Regenxbio’s earnings call transcripts.